Obesity is a key driver of insulin resistance and the development of type 2 diabetes, and it is also linked to an increased risk of certain cancers. Managing diabetes and obesity in patients with cancer presents unique challenges, as therapeutic goals often extend beyond glycemic control to support cancer treatment outcomes.
This complimentary live webinar will address the knowledge and practice gaps surrounding the pathophysiology of diabetes in cancer patients and the impact of antineoplastic therapies on diabetes management, helping clinicians refine strategies for this complex patient population.
Diabetes Management in Patients with Obesity-Associated Cancers will be held on Friday, November 14 at 1:00 PM EST.
11/14/2025
11/14/2026
Upon completion of this program, learners will be able to:
- Demonstrate the association between obesity and cancers
- Describe the goals of diabetes management in patients with obesity associated cancers
- Discuss the complexity of diabetes management in patients on oncologic treatment regimen
Endocrinologists are the primary target audience; however, all healthcare professionals including primary care physicians, nurse practitioners, nurses, physician associates and endocrine care professionals who treat patients with rare endocrine diseases in their practice may also access this program.
Dr. Lubaina Presswala, DO, FACE
Dr. James Flory, MD
Physicians
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
American Association of Clinical Endocrinology is approved by the California Board of Registered Nursing, Provider Number 17762, for 1 contact hour.